Sheba Medical Center, Israel’s largest medical center and a Newsweek top-10 ranked world’s best hospital for the previous four years, announced on Wednesday a new collaborative deal with Thomas Jefferson University to promote neuroscience research and clinical treatment at the two institutions.
The deal calls for constructing a cutting-edge neuroscience center on Sheba’s campus in Israel with doors slated to open in late 2024.
A Memorandum of Understanding inked at the new facility site by the two schools emphasized partnership in four major areas: academia, innovation, research and clinical care.
“We share a mutual vision with TJU that the world must accelerate the transformation of clinical care and forge a bold new path. This agreement is part of that goal,” said Professor Yitshak Kreiss, director of Sheba Medical Center. “Our collaboration in neuroscience will enable both of us to lead the way in the development and implementation of cutting-edge world-changing technology.”
The Neuroscience Center, to be built on Sheba’s campus outside of Tel Aviv, will concentrate on a variety of brain diseases like epilepsy, Parkinson’s disease, ALS, movement disorders, stem-cell research and behavioral disorders.
